GDF3 inhibits the growth of breast cancer cells and promotes the apoptosis induced by Taxol

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 6, 2012, Pages 1073-1079

  Li, Qiang ^a,b   Ling, Yichen ^a   Yu, Long ^a  

^a FUDAN UNIVERSITY   (China)

^b Cardiovascular Research Laboratories   (United States)

Author keywords

Apoptosis; Breast cancer; GDF3; Taxol; TGF superfamily

Indexed keywords

CAMPTOTHECIN; GROWTH DIFFERENTIATION FACTOR 3; MITOMYCIN C; PACLITAXEL; RAPAMYCIN; RECOMBINANT HUMAN GROWTH DIFFERENTIATION FACTOR 3; RECOMBINANT PROTEIN; SHORT HAIRPIN RNA; SMAD2 PROTEIN; UNCLASSIFIED DRUG; VINCRISTINE;

ANCHORAGE INDEPENDENT GROWTH; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; CELL STRAIN MCF 7; CLINICAL ARTICLE; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; DRUG MECHANISM; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; GROWTH DIFFERENTIATION FACTOR 3; HUMANS; PACLITAXEL; RECOMBINANT FUSION PROTEINS; TUMOR STEM CELL ASSAY;

EID: 84864354327     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1213-3     Document Type: Article

References (29)

1. Ananth S, Knebelmann B, Gruning W, Dhanabal M, Walz G, Stillman IE, Sukhatme VP (1999) Transforming growth factor beta1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma. Cancer Res 59:2210-2216
2. Andersson O, Bertolino P, Ibáñez CF (2007) Distinct and cooperative roles of mammalian Vg1 homologs GDF1 and GDF3 during early embryonic development. Dev Biol 11:500-511
3. Andersson O, Korach-Andre M, Reissmann E, Ibáñez CF, Bertolino P (2008) Growth/differentiation factor 3 signals through ALK7 and regulates accumulation of adipose tissue and diet-induced obesity. Proc Natl Acad Sci USA 105:7252-7256
4. Bierie B, Moses HL (2006) TGF-beta and cancer. Cytokine Growth Factor Rev 17:29-40
5. Bikfalvi A (1995) Significance of angiogenesis in tumour progression and metastasis. Eur J Cancer 31:1101-1104
6. Caricasole AA, van Schaik RH, Zeinstra LM, Wierikx CD, van Gurp RJ, van den Pol M, Looijenga LH, Oosterhuis JW, Pera MF, Ward A, de Bruijn D, Kramer P, de Jong FH, van den Eijndenvan Raaij AJ (1998) Human growth-differentiation factor 3 (hGDF3): developmental regulation in human teratocarcinoma cell lines and expression in primary testicular germ cell tumours. Oncogene 16:95-103
7. Chen C, Ware SM, Sato A, Houston-Hawkins DE, Habas R, Matzuk MM, Shen MM, Brown CW (2006) The Vg1-related protein Gdf3 acts in a Nodal signaling pathway in the pre-gastrulation mouse embryo. Development 133:319-329
8. Chin D, Boyle GM, Parsons PG, Coman WB (2004) What is transforming growth factor-beta (TGF-beta). Br J Plast Surg 57:215-221
9. Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577-584
10. Desruisseau S, Ghazarossian-Ragni E, Chinot O, Martin PM (1996) differgent effect of TGF-beta1 on growth and proteolytic modulation of human prostatic-cancer cell lines. Int J Cancer 66:796-801
11. Duhagon MA, Hurt EM, Sotelo-Silveira JR, Zhang X, Farrar WL (2010) Genomic profiling of tumor initiating prostatospheres. BMC Genomics 11:324
12. Elliott RL, Blobe GC (2005) Role of transforming growth factor beta in human cancer. J Clin Oncol 23:2078-2093
13. Ezeh UI, Turek PJ, Reijo RA, Clark AT (2005) Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 10: 2255-2265
14. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE (1996) DPC4, a candidate tumor suppressor gene athuman chromosome 18q21.1. Science 271:350-353
15. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57-70
16. Herpin A, Lelong C, Favrel P (2004) Transforming growth factorbeta- related proteins: an ancestral and widespread superfamily of cytokines in metazoans. Dev Comp Immunol 28:461-485
17. Katakura Y, Nakata E, Miura T, Shirahata S (1999) Transforming growth factor beta triggers two independent-senescence programs in cancer cells. Biochem Biophys Res Commun 255: 110-115
18. Levine AJ, Brivanlou AH (2006) GDF3, a BMP inhibitor, regulates cell fate in stem cells and early embryos. Development 133:209-216
19. Li Q, An J, Liu X, Zhang M, Ling Y, Wang C, Zhao J, Yu L (2012a) SNIP1: a new activator of HSE signaling pathway. Mol Cell Biochem 362:1-6
20. Li Q, Liu X, Wu Y, An J, Hexige S, Ling Y, Zhang M, Yang X, Yu L (2012b) The conditioned medium from a stable human GDF3- expressing CHO cell line, induces the differentiation of PC12 cells. Mol Cell Biochem 359:115-123
21. Massague J, Heino J, Laiho M (1991) Mechanisms in TGF-beta action. Ciba Found Symp 157:51-59
22. Massague J, Cheifetz S, Laiho M, Ralph DA, Weis FM, Zentella A (1992) Transforming growth factor-beta. Cancer Surv 12:81-103
23. Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K (2002) Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells 7:1191-1204
24. Perry RR, Kang Y, Greaves BR (1995) Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells. Br J Cancer 72:1441-1446
25. Shen JJ, Huang L, Li L, Jorgez C, Matzuk MM, Brown CW (2009) Deficiency of growth differentiation factor 3 protects against diet-induced obesity by selectively acting on white adipose. Mol Endocrinol 23:113-123
26. Torre-Amione G, Beauchamp RD, Koeppen H, Park BH, Schreiber H, Moses HL, Rowley DA (1990) A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance. Proc Natl Acad Sci USA 87:1486-1490
27. Wang W, Yang Y, Meng Y, Shi Y (2004) GDF-3 is an adipogenic cytokine under high fat dietary condition. Biochem Biophys Res Commun 321:1024-1031
28. Yan Z, Deng X, Friedman E (2001) OncogenicKi-ras confers a more aggressive colon cancer phenotype through modification of transforming growth factor-beta receptor III. J Biol Chem 276:1555-1563
29. Yingling JM, Blanchard KL, Sawyer JS (2004) Development of TGFbeta signalling inhibitors for cancer therapy. Nat Rev Drug Discov 3:1011-1022